Page last updated: 2024-09-03

sk&f 104856 and bmy 7378

sk&f 104856 has been researched along with bmy 7378 in 3 studies

Compound Research Comparison

Studies (sk&f 104856)	Trials (sk&f 104856)	Recent Studies (post-2010) (sk&f 104856)	Studies (bmy 7378)	Trials (bmy 7378)	Recent Studies (post-2010) (bmy 7378)
14	0	0	39	0	13
14	0	0	225	0	25

Protein Interaction Comparison

Protein	Taxonomy	bmy 7378 (IC50)
D	Rattus norvegicus (Norway rat)	0.091
D(3) dopamine receptor	Rattus norvegicus (Norway rat)	0.091
D(1B) dopamine receptor	Rattus norvegicus (Norway rat)	0.091
D(4) dopamine receptor	Rattus norvegicus (Norway rat)	0.091
D(2) dopamine receptor	Rattus norvegicus (Norway rat)	0.091

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Botta, M; Cagnotto, A; Manetti, F; Materia, L; Mennini, T; Minneman, KP; Nicoletti, F; Romeo, G; Russo, F	1
Pedretti, A; Testa, B; Villa, L; Vistoli, G	1
Ballard, S; Blagg, J; Fox, D; Kenny, B	1

Reviews

1 review(s) available for sk&f 104856 and bmy 7378

Article	Year
Pharmacological options in the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship	1997

Article

Year

Pharmacological options in the treatment of benign prostatic hyperplasia.

Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship

1997

Other Studies

2 other study(ies) available for sk&f 104856 and bmy 7378

Article	Year
New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes. Journal of medicinal chemistry, 2003, Jul-03, Volume: 46, Issue:14 Topics: Adrenergic alpha-Antagonists; Animals; Cell Line; Computer Simulation; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship	2003
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses. Journal of medicinal chemistry, 2005, Jul-28, Volume: 48, Issue:15 Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents	2005

Article

Year

New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.

Journal of medicinal chemistry, 2003, Jul-03, Volume: 46, Issue:14

Topics: Adrenergic alpha-Antagonists; Animals; Cell Line; Computer Simulation; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship

2003

Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.

Journal of medicinal chemistry, 2005, Jul-28, Volume: 48, Issue:15

Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents

2005